4.7 Editorial Material

BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies

Journal

RHEUMATOLOGY
Volume 49, Issue 11, Pages 2217-2219

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/rheumatology/keq249a

Keywords

Rheumatoid arthritis; British Society for Rheumatology; Guidelines; Anti-TNF therapies; Drug safety; Adverse event; Infliximab; Etanercept; Adalimumab

Categories

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available